Fractyl Health (GUTS) Director Christopher Thompson Receives Award

What Happened

• Christopher Charles Thompson, a director of Fractyl Health, was granted 22,500 derivative securities (stock options) on 2026-06-10 as compensation under the company's non-employee director policy. The Form 4 records the grant at $0.00 (no cash paid) and lists the transaction as an Award/Grant (code A).

Key Details

• Transaction date: 2026-06-10; Filing date: 2026-06-11 (filed the next day).
• Reported as 22,500 derivative shares granted at $0.00 (no cash outlay on grant).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote: The options vest and become exercisable in a single installment on the earlier of (i) the next annual meeting of stockholders or (ii) the first anniversary of the grant, subject to continued service as a non-employee director.
• No 10b5-1 plan, tax-withholding, cashless exercise, or late-filing flags noted in the provided details.

Context

• This was a compensation grant (award of options), not a market purchase or sale — options typically require vesting and later exercise to convert into common shares. Such awards are routine for board service and do not by themselves indicate insider buying or selling intent.